TLC-3595, a Selective Acetyl-CoA Carboxylase 2 (ACC2) Inhibitor, Improves Steatosis and Fibrosis in Murine Models of NASH via Pleiotropic Mechanisms [EASL 2023, Poster #2578]
OrsoBio team members collaborated with Professor Takebe in his pioneering study in Cell on the first use of en masse human liver organoids to define the genetic basis of metabolic liver disease and potential for tailored therapeutic development.
